Patent ID: 11879014
Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method according to claim 1, wherein the antibody is selected from the group consisting of:
(a) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 3 and the light chain comprising the amino acid sequence of SEQ ID NO:4;
(b) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 5 and the light chain comprising the amino acid sequence of SEQ ID NO: 6;
(c) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 10 and the light chain comprising the amino acid sequence of SEQ ID NO: 14;
(d) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 18 and the light chain comprising the amino acid sequence of SEQ ID NO: 22;
(d) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 23 and the light chain comprising the amino acid sequence of SEQ ID NO: 25;
(e) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 23 and the light chain comprising the amino acid sequence of SEQ ID NO: 26;
(f) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 24 and the light chain comprising the amino acid sequence of SEQ ID NO: 25;
(g) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 24 and the light chain comprising the amino acid sequence of SEQ ID NO: 26;
(h) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 27 and the light chain comprising the amino acid sequence of SEQ ID NO: 30;
(i) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 27 and the light chain comprising the amino acid sequence of SEQ ID NO: 31;
(j) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 27 and the light chain comprising the amino acid sequence of SEQ ID NO: 32;
(k) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 27 and the light chain comprising the amino acid sequence of SEQ ID NO: 33;
(l) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 28 and the light chain comprising the amino acid sequence of SEQ ID NO: 30;
(m) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 28 and the light chain comprising the amino acid sequence of SEQ ID NO: 31;
(n) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 28 and the light chain comprising the amino acid sequence of SEQ ID NO: 32;
(o) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 28 and the light chain comprising the amino acid sequence of SEQ ID NO: 33;
(p) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 29 and the light chain comprising the amino acid sequence of SEQ ID NO: 30;
(q) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 29 and the light chain comprising the amino acid sequence of SEQ ID NO: 31;
(r) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 29 and the light chain comprising the amino acid sequence of SEQ ID NO: 32; and
(s) an antibody comprising a heavy chain comprising the amino acid sequence of SEQ ID NO: 29 and the light chain comprising the amino acid sequence of SEQ ID NO: 33.